Evoke (LON:EVOK) Shares Down 18.7% – Here’s Why

Evoke plc (LON:EVOKGet Free Report) traded down 18.7% during trading on Wednesday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 58.05 ($0.75). 55,595,465 shares changed hands during mid-day trading, an increase of 1,853% from the average session volume of 2,847,325 shares. The stock had previously closed at GBX 71.40 ($0.92).

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank cut their price target on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th.

View Our Latest Analysis on Evoke

Evoke Stock Down 1.1 %

The stock has a market cap of £224.78 million, a P/E ratio of -1.26 and a beta of 0.84. The business has a 50-day simple moving average of GBX 68.88 and a 200-day simple moving average of GBX 63.49.

Evoke (LON:EVOKGet Free Report) last posted its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, analysts predict that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Andrea Gisle Joosen bought 14,572 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is owned by insiders.

About Evoke

(Get Free Report)

Featured Stories

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.